Proactive Investors - Run By Investors For Investors

Tavistock Investments at an 'inflection point'

Brian Raven, chief executive of Tavistock Investments PLC (LON:TAVI) runs through their results for the year to the end of March 2017.

Turnover was up 22% at £36.4mln giving EBITDA of £537,000, up 421%.

Cash generation was £497,000 in the second half.

The company saw its net assets more than double to £18.2mln in the period, while funds under management were ahead 332% at £769mln.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full TAVI profile View Profile

Tavistock Investments Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use